about us
Marshall Edwards is a San Diego based oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism.
[ Read more ]
our programs
Our two lead drug candidates have been shown to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism, a critical function for cancer cells.
[ Read more ]
latest news
Marshall Edwards Completes Rights Offering to Stockholders
[ May 14, 2012 ]
Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Oncology Drug Candidate ME-344
[ April 10, 2012 ]
Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO
[ April 3, 2012 ]